Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.
Elevated gonads load from DHB, Testosterone. Monitor this organ system closely.

Cumulative Organ Load

Gonads
elevated
Heart
moderate
Liver
low
Pancreas
low

Shared Safety Flags

2x 2 androgenic compounds (DHB, Testosterone). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the carcinogenic-risk safety flag (DHB, Testosterone). Monitor accordingly.
2x 2 estrogenic compounds (DHB, Testosterone). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 hepatotoxic compounds (DHB, Testosterone). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (DHB, Testosterone). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (DHB, Testosterone). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (DHB, Testosterone). Monitor accordingly.
++
DHB + Testosterone
Synergistic

A testosterone base is essential when running DHB. DHB suppresses endogenous testosterone production and does not aromatize, so without exogenous testosterone, estradiol levels will crash, leading to low-estrogen symptoms including joint pain, flat mood, low libido, and adverse lipid changes. Typical ratios are 1:4 to 1:2 DHB-to-testosterone (e.g., 200-400 mg DHB with 500-800 mg testosterone per week). The testosterone provides the estrogenic support that DHB cannot.

Researched 95% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.